Publication Name	World Journal of Virology
Manuscript ID	66296
Country	Spain

Received	2021-03-24 22:21
Peer-Review Started	2021-03-24 22:26
To Make the First Decision
Return for Revision	2021-05-05 21:17
Revised	2021-05-18 14:40
Second Decision	2021-08-13 02:57
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-08-13 07:27
Articles in Press	2021-08-13 07:27
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-10-06 09:12
Typeset the Manuscript	2021-11-18 05:28
Publish the Manuscript Online	2021-11-22 09:40

ISSN	2220-3249 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Impact of COVID-19 on liver disease: From the experimental to the clinic perspective
Manuscript Source	Invited Manuscript
All Author List	Sheila Gato, Ana Lucena-Valera, Rocío Muñoz-Hernández, José Manuel Sousa, Manuel Romero-Gómez and Javier Ampuero
Funding Agency and Grant Number
Corresponding Author	Javier Ampuero, MD, MSc, PhD, Doctor, Professor, Senior Scientist, Digestive Department, Hospital Universitario Virgen del Rocio, Avda. Manuel Siurot s/n, Sevilla 41013, Spain. javi.ampuero@gmail.com
Key Words	SARS-CoV-2; COVID 19; Liver disease; Transaminases
Core Tip	The outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed a critical threat to the global public health. Beyond the respiratory symptoms, some patients with COVID-19 show liver damage. In this scenario, it has been suggested that there might be a specific relationship between SARS-CoV-2 infection and liver injury.
Publish Date	2021-11-22 09:40
Citation	Gato S, Lucena-Valera A, Muñoz-Hernandez R, Sousa JM, Romero-Gómez M, Ampuero J. Impact of COVID-19 on liver disease: From the experimental to the clinic perspective. World J Virol 2021; 10(6): 301-311
URL	https://www.wjgnet.com/2220-3249/full/v10/i6/301.htm
DOI	https://dx.doi.org/10.5501/wjv.v10.i6.301

Full Article (PDF)	WJV-10-301.pdf
Full Article (Word)	WJV-10-301.docx
Manuscript File	66296_Auto_Edited-JPY-Webster J-Clear.docx
Answering Reviewers	66296-Answering reviewers.pdf
Audio Core Tip	66296-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	66296-Conflict-of-interest statement.pdf
Copyright License Agreement	66296-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	66296-Language certificate.pdf
Peer-review Report	66296-Peer-review(s).pdf
Scientific Misconduct Check	66296-Scientific misconduct check.pdf
Scientific Editor Work List	66296-Scientific editor work list.pdf